CA2519161A1 - Activite de sir2 - Google Patents

Activite de sir2 Download PDF

Info

Publication number
CA2519161A1
CA2519161A1 CA002519161A CA2519161A CA2519161A1 CA 2519161 A1 CA2519161 A1 CA 2519161A1 CA 002519161 A CA002519161 A CA 002519161A CA 2519161 A CA2519161 A CA 2519161A CA 2519161 A1 CA2519161 A1 CA 2519161A1
Authority
CA
Canada
Prior art keywords
sir2
compound
cell
cells
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002519161A
Other languages
English (en)
Inventor
Leonard P. Guarente
Homayoun Vaziri
Shin-Ichiro Imai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitehead Institute for Biomedical Research
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute Of Technology
Leonard P. Guarente
Homayoun Vaziri
Shin-Ichiro Imai
Whitehead Institute For Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute Of Technology, Leonard P. Guarente, Homayoun Vaziri, Shin-Ichiro Imai, Whitehead Institute For Biomedical Research filed Critical Massachusetts Institute Of Technology
Priority claimed from CA002453195A external-priority patent/CA2453195A1/fr
Publication of CA2519161A1 publication Critical patent/CA2519161A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002519161A 2001-07-06 2002-07-08 Activite de sir2 Abandoned CA2519161A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US30337001P 2001-07-06 2001-07-06
US30345601P 2001-07-06 2001-07-06
US60/303,370 2001-07-06
US60/303,456 2001-07-06
US19015902A 2002-07-05 2002-07-05
US10/190,159 2002-07-05
CA002453195A CA2453195A1 (fr) 2001-07-06 2002-07-08 Activite de sir2

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002453195A Division CA2453195A1 (fr) 2001-07-06 2002-07-08 Activite de sir2

Publications (1)

Publication Number Publication Date
CA2519161A1 true CA2519161A1 (fr) 2003-01-16

Family

ID=35767572

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002519161A Abandoned CA2519161A1 (fr) 2001-07-06 2002-07-08 Activite de sir2

Country Status (1)

Country Link
CA (1) CA2519161A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110687284A (zh) * 2019-08-26 2020-01-14 中国医学科学院肿瘤医院 检测血清中six2自身抗体的试剂的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110687284A (zh) * 2019-08-26 2020-01-14 中国医学科学院肿瘤医院 检测血清中six2自身抗体的试剂的应用

Similar Documents

Publication Publication Date Title
US8546074B2 (en) Sir2 activity
US20040005574A1 (en) SIR2 activity
Olsson et al. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
Novoa et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α
Bu et al. Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos
US20050136429A1 (en) SIRT1 modulation of adipogenesis and adipose function
CA2496897C (fr) Procedes et compositions permettant la modulation de l'activite xbp-1
JP2015180657A (ja) 細胞及び生物の寿命を延ばし、ストレス耐性を高めるための方法及び組成物
US20060063187A1 (en) Modulation of XBP-1 activity for treatment of metabolic disorders
Davé et al. Nuclear factor of activated T cells regulates transcription of the surfactant protein D gene (Sftpd) via direct interaction with thyroid transcription factor-1 in lung epithelial cells
JP2004524021A (ja) ＨｉｓＲＳをターゲッティングすることによるＳＲＥＢＰ経路の調節
AU2002320325B2 (en) SIR2 activity
AU2002320325A1 (en) SIR2 activity
Ghosh et al. Fibroblasts derived from patients with opsismodysplasia display SHIP2‐specific cell migration and adhesion defects
US20080229436A1 (en) Methods for identifying modulators of lifespan and resistance to oxidative stress
CA2519161A1 (fr) Activite de sir2
US6887675B1 (en) Tankyrase H, compositions involved in the cell cycle and methods of use
US20050074825A1 (en) Tankyrase H, compositions involved in the cell cycle and methods of use
WO2006031930A2 (fr) Modulation de l'activite de l'xbp-1 pour le traitement de troubles metaboliques
US20050065081A1 (en) Tyrosine kinase inhibitors
US20060153806A1 (en) Proteins involved in the regulation of energy homeostasis
US20060057669A1 (en) Inactive transcription factor tif-ia and uses thereof
US6482610B1 (en) Method for producing agents for treating tumor diseases and for immunosuppression
Cruz Identification of TICRR, a novel checkpoint and replication regulator
O'Connell Analysis of c-Myc-mediated G1 progression and identification of c-Myc target genes

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150429